| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer (NCT05361174) | Iovance Biotherapeutics, Inc. | 2022-07-20 |
| Ruxolitinib for Cancer Cachexia (NCT04906746) | Tu Dan | 2022-02-23 |
| Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer (NCT05588206) | First People's Hospital of Hangzhou | 2022-01-01 |
| Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC (NCT05176067) | Guizhou Medical University | 2021-12-30 |
| Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer (NCT06525246) | Ono Pharmaceutical Co., Ltd. | 2021-08-06 |
| Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer (NCT04670445) | Massachusetts General Hospital | 2021-01-23 |
| Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors (NCT04142931) | Dr. Ronnie Shapira | 2020-02-24 |
| Study of Crizotinib for ROS1 and MET Activated Lung Cancer (NCT04084717) | University Health Network, Toronto | 2019-12-03 |
| Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments (NCT04056247) | OncoHost Ltd. | 2019-10-01 |
| Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites (NCT04267575) | Jerome Canady, M.D. | 2019-07-30 |
| Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy (NCT03911219) | iOMEDICO AG | 2019-07-10 |
| BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium (NCT03959137) | MSD Belgium BVBA | 2019-06-03 |
| KN046 in Patients With Advanced Non-small Cell Lung Cancer (NCT03838848) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-05-05 |
| Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC (NCT03611738) | H. Lee Moffitt Cancer Center and Research Institute | 2019-02-01 |
| Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC (NCT03742687) | Danish Lung Cancer Group | 2018-11-22 |
| Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads (NCT03023904) | Vanderbilt-Ingram Cancer Center | 2017-12-29 |
| Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer. (NCT03119519) | Southern Medical University, China | 2017-12-11 |
| Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth (NCT03305380) | Maastricht Radiation Oncology | 2017-09-01 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer (NCT03121417) | Emory University | 2017-07-21 |
| Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT03048500) | Northwestern University | 2017-07-12 |
| Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT02947386) | Roswell Park Cancer Institute | 2017-06-29 |
| Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL) (NCT03176173) | Stanford University | 2017-06-28 |
| Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC (NCT02658097) | Case Comprehensive Cancer Center | 2017-06-07 |
| Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer (NCT03137771) | NRG Oncology | 2017-04-07 |
| Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations (NCT02949843) | Wake Forest University Health Sciences | 2017-03-10 |
| Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 (NCT03049618) | University of Southern California | 2017-03-10 |
| Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer (NCT03595644) | Tongji Hospital | 2017-02-12 |
| Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC (NCT04530708) | Swedish Lung Cancer Study Group | 2017-02-01 |
| TG4010 and Nivolumab in Patients With Lung Cancer (NCT02823990) | Megan Daly, MD | 2016-12-14 |
| A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer (NCT02831491) | Eli Lilly and Company | 2016-11-01 |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors (NCT02897375) | Emory University | 2016-10-24 |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) (NCT02728596) | SWOG Cancer Research Network | 2016-10-07 |
| Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases (NCT02858869) | Emory University | 2016-10-04 |
| Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer (NCT02879994) | Jonsson Comprehensive Cancer Center | 2016-09-15 |
| Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer (NCT02581943) | Wake Forest University Health Sciences | 2016-06-17 |
| Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer (NCT02451865) | Jonsson Comprehensive Cancer Center | 2016-06-01 |
| Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT02567396) | National Cancer Institute (NCI) | 2016-06-01 |
| Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography (NCT02819024) | Barbara Ann Karmanos Cancer Institute | 2016-06-01 |
| TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors (NCT02650635) | Mayo Clinic | 2016-02-05 |
| MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer (NCT02400814) | Megan Daly, MD | 2015-12-03 |
| Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer (NCT02655913) | Clifford Hospital, Guangzhou, China | 2015-12-01 |
| Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib (NCT02364609) | Jonathan Riess | 2015-09-30 |
| A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC (NCT02451930) | Eli Lilly and Company | 2015-09-04 |
| Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896) | University of Southern California | 2015-09-03 |
| 18F-FSPG PET/CT for Cancer Patients on Therapy (NCT02599194) | Andrei Iagaru | 2015-07-01 |
| S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer (NCT02438722) | SWOG Cancer Research Network | 2015-05-07 |
| Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3 (NCT02426658) | Wake Forest University Health Sciences | 2015-05-01 |
| Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer (NCT02132884) | Fox Chase Cancer Center | 2015-03-01 |
| Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT02009436) | Albert Einstein College of Medicine | 2015-02-09 |
| Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers (NCT02243748) | City of Hope Medical Center | 2015-02-01 |
| Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer (NCT02470468) | SOTIO a.s. | 2014-12-01 |
| S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib (NCT02134912) | SWOG Cancer Research Network | 2014-08-01 |
| Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer (NCT02178163) | Barbara Ann Karmanos Cancer Institute | 2014-08-01 |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer (NCT02206334) | NRG Oncology | 2014-08-01 |
| Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer (NCT02245100) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2014-07-22 |
| Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection (NCT02134886) | National Cancer Institute (NCI) | 2014-07-01 |
| Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer (NCT02145078) | Barbara Ann Karmanos Cancer Institute | 2014-06-01 |
| Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib (NCT01928160) | Vanderbilt-Ingram Cancer Center | 2014-06-01 |
| Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer (NCT01737502) | Mayo Clinic | 2014-05-14 |
| Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial (NCT02045446) | University of Texas Southwestern Medical Center | 2014-02-01 |
| Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer (NCT01784640) | Jonsson Comprehensive Cancer Center | 2014-01-31 |
| Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens (NCT01948141) | Roswell Park Cancer Institute | 2014-01-30 |
| Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients (NCT01999881) | University of Wisconsin, Madison | 2013-12-01 |
| Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection (NCT01249443) | AIDS Malignancy Consortium | 2013-11-01 |
| Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation (NCT02017925) | Ohio State University Comprehensive Cancer Center | 2013-10-01 |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers (NCT01935336) | University of Colorado, Denver | 2013-09-24 |
| Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer (NCT01839955) | Neelesh Sharma MD PhD | 2013-09-01 |
| PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer (NCT02073968) | Albert Einstein College of Medicine | 2013-07-01 |
| PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer (NCT01723800) | City of Hope Medical Center | 2013-07-01 |
| Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT01935947) | National Cancer Institute (NCI) | 2013-05-01 |
| Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer (NCT01781741) | Roswell Park Cancer Institute | 2013-03-06 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer (NCT01620190) | University of Washington | 2012-12-02 |
| Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers (NCT01729689) | Stanford University | 2012-11-01 |
| Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer (NCT01664754) | Jonsson Comprehensive Cancer Center | 2012-09-07 |
| Circulating Tumor Cells in Lung Cancer (NCT01658332) | Central Hospital, Nancy, France | 2012-06-01 |
| Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer (NCT01528137) | Stanford University | 2012-05-01 |
| Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer (NCT01383668) | Mayo Clinic | 2011-06-01 |
| Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer (NCT01282333) | National Cancer Institute (NCI) | 2011-01-01 |
| MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC (NCT01310244) | Acrotech Biopharma Inc. | 2010-12-01 |
| RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy (NCT01193868) | National Cancer Institute (NCI) | 2010-09-01 |
| RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT01193881) | National Cancer Institute (NCI) | 2010-08-01 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT00955305) | National Cancer Institute (NCI) | 2010-03-01 |
| Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer (NCT00976677) | National Cancer Institute (NCI) | 2010-01-01 |
| Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer (NCT01026467) | Wake Forest University Health Sciences | 2010-01-01 |
| A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC (NCT00963807) | National Cancer Institute (NCI) | 2009-09-01 |
| Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00778167) | National Cancer Institute (NCI) | 2008-10-01 |
| Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00738881) | National Cancer Institute (NCI) | 2008-10-01 |
| AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy (NCT00638937) | National Cancer Institute (NCI) | 2008-02-01 |
| Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer (NCT00602797) | University of Nebraska | 2007-12-17 |
| Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis (NCT01014598) | Roswell Park Cancer Institute | 2007-12-04 |
| Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NCT00499655) | City of Hope Medical Center | 2007-11-01 |
| FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer (NCT00564733) | University of Washington | 2007-10-01 |
| Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT01557959) | Wake Forest University Health Sciences | 2007-07-01 |
| Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00481078) | National Cancer Institute (NCI) | 2007-05-01 |
| Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00459342) | National Cancer Institute (NCI) | 2007-03-01 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |